AIG
BDTX icon

American International Group’s Black Diamond Therapeutics BDTX Stock Holding History

American International Group’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,309
Closed -$31K – 3106
2022
Q1 		$31K Sell
11,309
-794
-7% -$2.9K ﹤0.01% 2969
2021
Q4 		$65K Sell
12,103
-363
-3% -$2.54K ﹤0.01% 2872
2021
Q3 		$105K Sell
12,466
-296
-2% -$2.92K ﹤0.01% 2785
2021
Q2 		$156 Buy
12,762
+2,223
+21% +$43.9K ﹤0.01% 2659
2021
Q1 		$256 Buy
10,539
+29
+0.3% +$782 ﹤0.01% 2234
2020
Q4 		$337 Sell
10,510
-302
-3% -$9.92K ﹤0.01% 1986
2020
Q3 		$327K Buy
10,812
+3,295
+44% +$100K ﹤0.01% 1823
2020
Q2 		$317K Buy
7,517
+374
+5% +$13.8K ﹤0.01% 1839
2020
Q1 		$178K Buy
+7,143
New +$217K ﹤0.01% 1965

Other funds holding BDTX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

American International Group's BDTX Position: Q2 2022 in Review

American International Group sold out of Black Diamond Therapeutics (BDTX) in Q2 2022, closing a stake of 11,309 shares — an estimated $31K sold.

American International Group first reported a position in BDTX in Q1 2020 and held it in 9 quarters. The position peaked at $327K in Q3 2020. 74 funds tracked by Wall St. Rank hold BDTX as of Q2 2022.

  • American International Group reported no remaining Black Diamond Therapeutics position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 11,309 Black Diamond Therapeutics shares in Q2 2022, an estimated $31K.
  • American International Group first reported a position in Black Diamond Therapeutics in Q1 2020 and held it in 9 quarters.
  • American International Group's Black Diamond Therapeutics position peaked at $327K in Q3 2020.
  • 74 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.